Group 1: Value Management Strategies - The company emphasizes value management by focusing on core business operations and enhancing operational efficiency and profitability, in line with the CSRC's guidelines [2] - Cash dividends for 2024 are proposed at 2.00 RMB per 10 shares, totaling 43,001,596.00 RMB [3] - A share buyback plan is set with a budget between 20 million and 40 million RMB, with an initial buyback of 178,100 shares, representing 0.0828% of total shares [3] - The company has engaged with nearly 90 institutions over 20 times in the past year to strengthen investor relations [3] Group 2: Product and Market Insights - The domestic market capacity for alkyl glycosides is estimated at 150,000 to 200,000 tons, with the largest application areas being pesticides and daily chemicals [5] - The company has a current production capacity of 35,000 tons/year for alkyl glycosides, with expansion plans underway to meet increasing demand [6] - The utilization rate for alkyl glycosides in 2024 is projected to reach 100%, while the utilization rate for polyether amines is approximately 46% [9] Group 3: Research and Development Initiatives - The company is investing in the development of bio-based polyol products, which have shown promising initial results and are expected to open new market opportunities [7] - Sales of polyether amines in specialized fields exceeded 1 million RMB in 2024 [7] - The promotion of alkyl glycosides in high-end cosmetics has resulted in sales of over 21 tons in 2024 [7] Group 4: Corporate Structure and Future Plans - The company has established Jiangsu Dajiang New Materials Chemical Co., Ltd. in partnership with Dajiang Chemical, with a registered capital of 150 million RMB [8] - The company remains committed to growth through mergers and acquisitions, with decisions subject to board and shareholder approval [8]

Group 1: Share Buyback and Financial Strategy - The company plans to implement a share buyback starting from May 13, 2025, for a period of 12 months, with disclosures to be made as per regulations [2] - The 2024 profit distribution plan includes a cash dividend of 2.00 CNY per 10 shares, totaling 43,001,596.00 CNY [4] - The company intends to use between 20 million and 40 million CNY for share repurchase, with all repurchased shares to be canceled [5] Group 2: Production and R&D Facilities - The company has one headquarters and two R&D bases located in Nanjing and Fuzhou, along with two production bases in Yangzhou and Huai'an [2] - The Huai'an facility is expanding its production capacity for alkyl glycosides by 35,000 tons per year, with plans to commence production in 2025 [3] Group 3: Market and Product Insights - The domestic market capacity for alkyl glycosides is estimated to be around 150,000 to 200,000 tons, with the largest application fields being pesticides and daily chemicals [3] - The consumption ratio of fatty alcohols in alkyl glycosides ranges from 19.5% to 23.5% [3] Group 4: M&A Strategy - The company is focusing on acquiring businesses with annual revenues between 100 million and 1.5 billion CNY, particularly in the biochemistry or electronic chemistry sectors [6] - The target net profit for potential acquisitions is between 30 million and 100 million CNY, with a preference for companies with at least two core technology products [6] Group 5: Future R&D Projects - The company is investing in the development of bio-based polyols, which have shown promising initial results and are expected to enhance profit margins [7] - Sales of polyether amines in specialized fields exceeded 1 million CNY in 2024 [7] - The promotion of alkyl glycosides in high-end cosmetics has resulted in sales of over 21 tons in 2024 [7]